計畫
(Principal Investigator)


第 1 到 19 筆結果，共 19 筆。

啟始時間標題P-Investigator經費來源
2023Molecular Mechanism of Inhibition of Thymidine Phosphorylase Expression by Hsp90 Inhibitor Potentiates the Cytotoxic Effect of Estrogen Receptor Antagonist and Egfr-Tkis in Human Non-Small-Cell Lung Cancer CellsJEN-CHUNG KONational Science and Technology Council
2022Molecular Mechanism of Inhibition of Thymidine Phosphorylase Expression by Hsp90 Inhibitor Potentiates the Cytotoxic Effect of Estrogen Receptor Antagonist and Egfr-Tkis in Human Non-Small-Cell Lung Cancer CellsJEN-CHUNG KONational Science and Technology Council
2021Molecular Mechanism of Inhibition of Thymidine Phosphorylase Expression by Hsp90 Inhibitor Potentiates the Cytotoxic Effect of Estrogen Receptor Antagonist and Egfr-Tkis in Human Non-Small-Cell Lung Cancer CellsJEN-CHUNG KONational Science and Technology Council
2020Investigate the Molecular Mechanism of Nitroglycerin to Enhance Chemotherapeutic Drug Cisplatin and Pemetrexed-Induced Cytotoxicity via Down-Regulation of Thymidylate Synthase Expression in Human Non-Small Cell Lung Cancer CellsJEN-CHUNG KONational Science and Technology Council
2018探討核酸錯誤配對修補蛋白MSH2的表現在薑黃素處理下會增加肺癌細胞對化療藥物gemcitabine(健擇)敏感性的角色JEN-CHUNG KONTU Hsin-Chu Hospital
2018Role of Down-Regulation of Thymidylate Synthase (Ts) and Aldehyde Dehydrogenase 1a1 (Aldh1a1) Expression in Salinomycin and Nitroglycerin to Enhance the Drug Sensitivity of Cisplatin in Human Non-Small Cell Lung Cancer CellsJEN-CHUNG KONational Science and Technology Council
2017探討程序性死亡配體1(PD-L1)抑制劑在增強艾瑞莎與順鉑在人類非小細胞肺癌的毒殺效果JEN-CHUNG KONTU Hsin-Chu Hospital
2016探討乙醛去氫酶1A1抑制劑在增強得舒緩與愛寧達在人類非小細胞肺癌的毒殺效果JEN-CHUNG KONTU Hsin-Chu Hospital
2016Role of metformin down-regulates MSH2 expression via inactivation of MKK3/6-p38 MAPK signal to enhance gefitinib-induced cytotoxicity in human non-small cell lung cancer cellsJEN-CHUNG KONational Science and Technology Council
2015探討葡萄糖轉運蛋白-1 及葡萄糖轉運蛋白-3 在調控核酸合成與修補分子表現JEN-CHUNG KONTU Hsin-Chu Hospital
2015雌性激素受體拮抗劑向下調控thymidine phosphorylase表現在增加表皮生長因子受體抑制劑與化療藥物毒殺非小細胞肺癌細胞的分子機轉JEN-CHUNG KONational Science and Technology Council
2014探討甲狀腺轉錄因子-1在調控核酸合成與修補分子表現以增強艾瑞莎與愛寧達在人類肺腺癌細胞的毒殺效果JEN-CHUNG KONTU Hsin-Chu Hospital
2013一氧化氮影響EGFR-TKI在肺癌細胞產生抗藥性的探討JEN-CHUNG KONTU Hsin-Chu Hospital
2013探討他莫昔芬調控核酸合成與修補分子以增強得舒緩在人類非小細胞肺癌細胞毒殺效果之分子機轉JEN-CHUNG KONTU Hsin-Chu Hospital
2013Molecular Mechanism of Metformin Mediated Down-Regulation of Thymidine Phosphorylase Expression in Enhancing Sensitivity of Cisplatin and Gefitinib to Human Lung Cancer CellsJEN-CHUNG KONational Science and Technology Council
2012以表皮生長因子受體抑制劑與胸腺嘧啶核苷酸合成酶抑制劑合併處理對人類小細胞肺癌細胞的加強毒殺效果與分子機轉之探討JEN-CHUNG KONTU Hsin-Chu Hospital
2012探討滅糖敏增強得舒緩在人類非小細胞肺癌細胞毒殺效果之分子機轉JEN-CHUNG KONTU Hsin-Chu Hospital
2011探討得舒緩在非小細胞肺癌細胞內對於熱休克蛋白90表現量之影響與是否能增強熱休克蛋白90抑制劑對非小細胞肺癌之細胞毒殺作用JEN-CHUNG KONTU Hsin-Chu Hospital
2011探討得舒緩協同一氧化氮合成酶抑制劑在非小細胞肺癌標靶治療的分子機轉JEN-CHUNG KONTU Hsin-Chu Hospital